Literature DB >> 33285297

In vivo therapeutic applications of phosphorus dendrimers: state of the art.

Serge Mignani1, Xiangyang Shi2, Valentin Ceña3, Dzmitry Shcharbin4, Maria Bryszewska5, Jean-Pierre Majoral6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 33285297     DOI： 10.1016/j.drudis.2020.11.034

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN： 1359-6446            Impact factor:   7.851


× No keyword cloud information.
  4 in total

Review 1.  Pulmonary delivery of siRNA against acute lung injury/acute respiratory distress syndrome.

Authors:  Makhloufi Zoulikha; Qingqing Xiao; George Frimpong Boafo; Marwa A Sallam; Zhongjian Chen; Wei He
Journal:  Acta Pharm Sin B       Date:  2021-08-12       Impact factor: 11.413

2.  Engineered Neutral Phosphorous Dendrimers Protect Mouse Cortical Neurons and Brain Organoids from Excitotoxic Death.

Authors:  Inmaculada Posadas; Laura Romero-Castillo; Rosa-Anna Ronca; Andrii Karpus; Serge Mignani; Jean-Pierre Majoral; Mariángeles Muñoz-Fernández; Valentín Ceña
Journal:  Int J Mol Sci       Date:  2022-04-15       Impact factor: 6.208

Review 3.  Engineered phosphorus dendrimers as powerful non-viral nanoplatforms for gene delivery: a great hope for the future of cancer therapeutics.

Authors:  Serge Mignani; Xiangyang Shi; Maria Bryszewska; Dzmitry Shcharbin; Jean-Pierre Majoral
Journal:  Explor Target Antitumor Ther       Date:  2022-02-25

Review 4.  First-in-Class Phosphorus Dendritic Framework, a Wide Surface Functional Group Palette Bringing Noteworthy Anti-Cancer and Anti-Tuberculosis Activities: What Lessons to Learn?

Authors:  Serge Mignani; Jérôme Bignon; Xiangyang Shi; Jean-Pierre Majoral
Journal:  Molecules       Date:  2021-06-17       Impact factor: 4.411
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.